智通财经APP获悉,国金证券发布研报称,2025年12月7日,国家医保局发布《2025新版基本医保药品目录》及首个《商业健康保险创新药品目录》,新版药品目录自2026年1月1日起正式执行。得益于创新药突出的临床价值,2025年新药谈判成功率较同期实现显著提升,此类药品预计将收获良好的谈判结果。随着相关药物纳入医保,产品有望快速放量并提升市场份额,新机制药物持续涌现,其快速打开终端市场并实现普惠覆盖...
Source Link智通财经APP获悉,国金证券发布研报称,2025年12月7日,国家医保局发布《2025新版基本医保药品目录》及首个《商业健康保险创新药品目录》,新版药品目录自2026年1月1日起正式执行。得益于创新药突出的临床价值,2025年新药谈判成功率较同期实现显著提升,此类药品预计将收获良好的谈判结果。随着相关药物纳入医保,产品有望快速放量并提升市场份额,新机制药物持续涌现,其快速打开终端市场并实现普惠覆盖...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.